Yanrong Ma

509 total citations
49 papers, 374 citations indexed

About

Yanrong Ma is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Yanrong Ma has authored 49 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 9 papers in Molecular Biology. Recurrent topics in Yanrong Ma's work include Drug Transport and Resistance Mechanisms (20 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). Yanrong Ma is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). Yanrong Ma collaborates with scholars based in China, New Zealand and Australia. Yanrong Ma's co-authors include Xinan Wu, Zhi Rao, Hongyan Qin, Yan Zhou, Guoqiang Zhang, Mingkang Zhang, Axi Shi, Yuhui Wei, Lili Xi and Xinyi Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Life Sciences.

In The Last Decade

Yanrong Ma

43 papers receiving 368 citations

Peers

Countries citing papers authored by Yanrong Ma

Since Specialization

Citations

This map shows the geographic impact of Yanrong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanrong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanrong Ma more than expected).

Fields of papers citing papers by Yanrong Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanrong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanrong Ma. The network helps show where Yanrong Ma may publish in the future.

Co-authorship network of co-authors of Yanrong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yanrong Ma. A scholar is included among the top collaborators of Yanrong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanrong Ma. Yanrong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions 2025 ·Precision Clinical Medicine ·Yanrong Ma, Jing Mu, (unknown), (unknown)	1
2	Supplementation With Curcumin Exhibits Nephroprotective Effects in Cisplatin‐Induced Acute Kidney Injury 2025 ·Food Science & Nutrition ·Mingkang Zhang, (unknown), (unknown), Yan Zhou, Yanrong Ma, (unknown)	0
3	Acute kidney injury and energy metabolism 2025 ·Clinica Chimica Acta ·Mingkang Zhang, Yanrong Ma, (unknown), (unknown), (unknown)	0
4	Analysis of volatile organic compounds in ten types of tribute Rice based on headspace-gas chromatography-ion mobility spectrometry technology 2025 ·Food Chemistry X ·Qianqian Jia, Yanrong Ma, Wang Bi, (unknown)	2
5	Haploides A–G: Diterpenoids featuring four new carbon skeletons via non-carbocation-driven skeletal diversification 2025 ·Chinese Chemical Letters ·(unknown), Zejun Xu, Jiao‐Zhen Zhang, Lei Shi, Zhiyuan Gao, Yi Li, (unknown), Yanrong Ma, Ai‐Xia Cheng, (unknown)	0
6	The toxicity of cisplatin derives from effects on renal organic ion transporters expression and serum endogenous substance levels 2024 ·Food and Chemical Toxicology ·Mingkang Zhang, (unknown), Yanrong Ma, (unknown), (unknown), (unknown), (unknown), (unknown)	2
7	Gallbladder cancer incidence and mortality rate trends in China: analysis of data from the population-based cancer registry 2024 ·BMC Public Health ·Xinzhou Zhang, (unknown), Han Zhang, Xinxin Du, Quanyu Zhang, Manman Lu, Yanrong Ma, Wenjun Ma	1
8	Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology 2024 ·Amino Acids ·(unknown), Yanrong Ma, Mingkang Zhang, (unknown), (unknown), (unknown), Yuhui Wei, Xinan Wu	6
9	Nephropathy induced by cisplatin results from mitochondrial disruption, impaired energy metabolism, altered expression of renal transporters, and accumulation of urinary toxins 2024 ·Journal of Trace Elements in Medicine and Biology ·Mingkang Zhang, Jianping Zhang, Yanrong Ma, (unknown), (unknown), (unknown)	1
10	Wolfram syndrome type 1: a case series 2023 ·Orphanet Journal of Rare Diseases ·Danyang Du, (unknown), Yanrong Ma, (unknown), Suli Li, Guoying Ma, (unknown), Yanying Guo	5
11	Accumulation of Renal Fibrosis in Hyperuricemia Rats Is Attributed to the Recruitment of Mast Cells, Activation of the TGF-β1/Smad2/3 Pathway, and Aggravation of Oxidative Stress 2023 ·International Journal of Molecular Sciences ·Mingkang Zhang, Ruirui Cui, Yan Zhou, Yanrong Ma, (unknown), Lina Wang, (unknown), (unknown)	6
12	Erythropoietin promotes energy metabolism to improve LPS-induced injury in HK-2 cells via SIRT1/PGC1-α pathway 2022 ·Molecular and Cellular Biochemistry ·(unknown), Li Gao, Sen Zhou, Yanrong Ma, Xiao Xiao, Qian Jiang, Zhihong Kang, (unknown), (unknown)	16
13	rhEPO inhibited cell apoptosis to alleviate acute kidney injury in sepsis by AMPK/SIRT1 activated autophagy 2019 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Junfeng Li, Yanrong Ma, (unknown), Yiqing Wang, Rong Wu, Bin Li, (unknown), Cheng Chen	33
14	Alteration of renal excretion pathways in gentamicin‐induced renal injury in rats 2018 ·Journal of Applied Toxicology ·Yanrong Ma, Xuan Luo, Yanfang Wu, (unknown), Fan Zhang, Guoqiang Zhang, Xinan Wu	7
15	Different lipid profiles, insulin sensitivity, and insulin resistance among Han, Uygur, and Kazak men with normal glucose tolerance in Xinjiang, China 2018 ·Lipids in Health and Disease ·(unknown), Jun Zhang, Yanrong Ma, (unknown), Suli Li, (unknown), Lan Wu	3
16	Effect of high uric acid on the disposition of metformin: in vivo and in vitro studies 2018 ·Biopharmaceutics & Drug Disposition ·Guoqiang Zhang, Yanrong Ma, (unknown), Zhi Rao, (unknown), Xinan Wu	11
17	Effect of cholecystectomy on bile acids as well as relevant enzymes and transporters in mice: Implication for pharmacokinetic changes of rifampicin 2016 ·European Journal of Pharmaceutical Sciences ·Fan Zhang, Hongyan Qin, (unknown), Yuhui Wei, Lili Xi, Zhi Rao, Jianping Zhang, Yanrong Ma, (unknown), Xinan Wu	16
18	Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats 2015 ·European Journal of Drug Metabolism and Pharmacokinetics ·Yanrong Ma, Hongyan Qin, (unknown), (unknown), (unknown), Xingdong Wang, Guoqiang Zhang, Yan Zhou, Zhi Rao, Xinan Wu	14
19	Simultaneous Determination of Metformin, Metoprolol and its Metabolites in Rat Plasma by LC–MS-MS: Application to Pharmacokinetic Interaction Study 2015 ·Journal of Chromatographic Science ·Yanrong Ma, Zhi Rao, Axi Shi, Ya-Feng Wang, (unknown), (unknown), Xindong Wang, (unknown), Guoqiang Zhang, Yan Zhou, Fan Zhang, Hongyan Qin, Xinan Wu	32
20	Inhibitory effect of atenolol on urinary excretion of metformin via down-regulating multidrug and toxin extrusion protein 1 (rMate1) expression in the kidney of rats 2014 ·European Journal of Pharmaceutical Sciences ·Yanrong Ma, (unknown), (unknown), (unknown), Guoqiang Zhang, Yan Zhou, Zhi Rao, Hongyan Qin, Xinan Wu	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact